tiprankstipranks
Sartorius Stedim Biotech (GB:0RG8)
LSE:0RG8
Holding GB:0RG8?
Track your performance easily

Sartorius Stedim Biotech (0RG8) Cash flow

2 Followers

Sartorius Stedim Biotech Cash Flow

GB:0RG8's free cash flow for Q4 2022 was €77.70M. For the 2022 fiscal year, GB:0RG8's free cash flow was decreased by €-181.70M and operating cash flow was €219.60M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
€ 612.30M-€ 612.30M€ 701.90M€ 416.88M€ 310.13M
Investing Cash Flow
€ -957.50M-€ -957.50M€ -465.20M€ -621.12M€ -184.37M
Financing Cash Flow
€ 220.70M-€ 220.70M€ -77.70M€ 234.07M€ -122.16M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
€ 573.80M-€ 107.10M€ 223.60M€ 59.76M€ 28.17M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
------
Issuance Of Debt
€ 566.80M-€ 566.80M€ 74.20M€ 334.79M€ 651.00K
Repayment Of Debt
€ -174.40M-€ -174.40M€ -79.70M€ -35.32M€ -60.49M
Free Cash Flow
€ 181.70M-€ 181.70M€ 377.90M€ 416.88M€ 174.16M
Domestic Sales
------
Foreign Sales
------
Currency in EUR

Sartorius Stedim Biotech Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis